Virbac Enhances Its Offerings with Felanorm Acquisition
Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats.
Understanding Feline Hyperthyroidism
Feline hyperthyroidism affects a substantial number of senior cats, with estimates suggesting that over ten percent of them are impacted. This endocrine disorder arises from an imbalance in hormone levels and can lead to various health complications if left untreated. Symptoms include weight loss, increased irritability, heart rate fluctuations, and gastrointestinal disturbances. In severe cases, it can be life-threatening.
The Role of Felanorm
With the introduction of Felanorm® (methimazole) Oral Solution to the U.S. market, Virbac provides the first FDA-approved oral therapy for this condition. The versatility of the liquid formula allows pet owners and veterinarians to manage dosages more effectively, resulting in a significant improvement in the day-to-day lives of both affected cats and their caregivers.
Paul Martingell's Vision
Paul Martingell, the CEO of Virbac Group, expressed enthusiasm regarding this acquisition, stating that it aligns perfectly with their mission to support animal health through innovative solutions. Martingell highlighted the importance of addressing challenging health conditions, stating that their investment reaffirms Virbac's ability to be the preferred partner for companies developing innovative treatments. The integration with Norbrook is anticipated to be smooth, and it is clear that the company is dedicated to promoting the health of senior cats.
Safety and Precautions
While Felanorm offers significant benefits, it is crucial for pet owners and veterinarians to remain informed about its use. The medication is not recommended for pregnant or nursing cats, as well as those with pre-existing kidney, liver, or blood disorders. Methimazole carries the potential for anticoagulant effects and may lead to bleeding difficulties, making it essential to adhere to the prescribing information.
About Virbac
At Virbac, the commitment to animal health is unwavering. The company prides itself on continuously seeking advancements in prevention, diagnosis, and treatment of various animal health issues. By crafting a range of products that span care, hygiene, and nutrition, Virbac aims to provide comprehensive solutions tailored for veterinarians, farmers, and pet owners alike. Their primary goal is to enhance the quality of life for animals, ensuring that those who care for them can also enjoy a better life.
Looking Ahead
The acquisition of Felanorm represents not only a growth opportunity for Virbac but also a significant step forward in providing critical care to senior cats suffering from hyperthyroidism. With the ongoing collaboration with major stakeholders in veterinary care, Virbac is poised to enhance its market presence while continuing to prioritize animal welfare through innovative treatments.
Frequently Asked Questions
What is Felanorm?
Felanorm is an FDA-approved oral solution for treating feline hyperthyroidism, particularly effective for senior cats.
How does feline hyperthyroidism affect cats?
This condition leads to hormonal imbalances, causing weight loss, irritability, and other health issues that can become life-threatening without treatment.
What can pet owners expect from Felanorm?
This solution allows for precise dosing, making it easier for veterinarians and owners to manage treatment effectively.
What precautions should be taken with Felanorm?
The medication should not be used by pregnant or lactating queens, or cats with certain health issues, as it can induce bleeding problems.
What is Virbac's mission?
Virbac's mission is to advance animal health by offering innovative treatments and solutions that improve the lives of pets and their caregivers.
